Evidence map›Paper›PMID 29985131›Full record

ArticleeLife2018

PARP1-dependent recruitment of the FBXL10-RNF68-RNF2 ubiquitin ligase to sites of DNA damage controls H2A.Z loading.

Gergely Rona, Domenico Roberti, Yandong Yin, Julia K Pagan, Harrison Homer, Elizabeth Sassani, Andras Zeke, Luca Busino, Eli Rothenberg, Michele Pagano

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nucleoporins cooperate with Polycomb silencers to promote transcriptional repression and repair at DNA double-strand breaks.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Histone H2A variants: Diversifying chromatin to ensure genome integrity.Seminars in cell & developmental biology · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Gergely Rona *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.ORCID 0000-0003-3222-7261
Domenico Roberti *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.
Yandong YinDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.ORCID 0000-0003-2499-871X
Julia K PaganDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.
Harrison HomerDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.ORCID 0000-0002-7157-0196
Elizabeth SassaniDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.
Andras ZekeInstitute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
Luca BusinoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.ORCID 0000-0001-6758-9276
Eli RothenbergDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.ORCID 0000-0002-1382-1380
Michele PaganoDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, United States.ORCID 0000-0003-3210-2442
New York University · USHoward Hughes Medical Institute · USInstitute of Molecular Life Sciences · HU

Funding

REGULATION OF THE GI PHASE BY THE UBIQUITIN PATHWAYR01GM057587 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2018
$7.8M
PH REGULATION OF CONNEXIN43--INTERMEDIARY STEPSR01GM057691 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI DELMAR, MARIO · 1999 to 2016
$5.6M
F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in CancerR01CA076584 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2021
$4.5M
Single-Molecule Studies of Non-Homologous DNA End JoiningR01GM108119 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2019
$1.7M
Single-molecule studies of BRCA1-BACH1 mechanism in genomic integrityR21CA187612 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2015 to 2016
$451k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA076584NCI NIH HHS R21 CA187612NIGMS NIH HHS R01 GM057587NIGMS NIH HHS R01 GM057691NIH HHS R01-CA076584NIH HHS R01-GM057587NIH HHS R01- GM057691NIH HHS R21-CA187612
6 · The paper itself

Abstract

The mammalian FBXL10-RNF68-RNF2 ubiquitin ligase complex (FRRUC) mono-ubiquitylates H2A at Lys119 to repress transcription in unstressed cells. We found that the FRRUC is rapidly and transiently recruited to sites of DNA damage in a PARP1- and TIMELESS-dependent manner to promote mono-ubiquitylation of H2A at Lys119, a local decrease of H2A levels, and an increase of H2A.Z incorporation. Both the FRRUC and H2A.Z promote transcriptional repression, double strand break signaling, and homologous recombination repair (HRR). All these events require both the presence and activity of the FRRUC. Moreover, the FRRUC and its activity are required for the proper recruitment of BMI1-RNF2 and MEL18-RNF2, two other ubiquitin ligases that mono-ubiquitylate Lys119 in H2A upon genotoxic stress. Notably, whereas H2A.Z is not required for H2A mono-ubiquitylation, impairment of the latter results in the inhibition of H2A.Z incorporation. We propose that the recruitment of the FRRUC represents an early and critical regulatory step in HRR.

Indexed as

DNA DamageCell LineDNA RepairF-Box ProteinsHistonesHomologous RecombinationHumansJumonji Domain-Containing Histone DemethylasesKineticsLysinePoly (ADP-Ribose) Polymerase-1Polycomb Repressive Complex 1Protein DomainsProtein MultimerizationProtein SubunitsRNA, Small InterferingF-Box Proteinshistone H2A.F-ZHistonesJumonji Domain-Containing Histone DemethylasesKDM2A protein, humanLysinePARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Polycomb Repressive Complex 1Protein SubunitsRNA, Small InterferingRNF2 protein, humanBMI1chromosomesDNA damage responseDNA repairFBXL10gene expressionH2A.ZhumanMEL18PARPRNF2RNF68TIMELESS

Identifiers

PMID29985131
PMCPMC6037479
OpenAlexW2870438257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.